Trial Profile
A single centre study to evaluate the whether the hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 12 Dec 2015 New trial record